Atif A Hashmi

2.1k total citations
136 papers, 1.4k citations indexed

About

Atif A Hashmi is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Atif A Hashmi has authored 136 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pathology and Forensic Medicine, 37 papers in Oncology and 33 papers in Surgery. Recurrent topics in Atif A Hashmi's work include Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (23 papers) and HER2/EGFR in Cancer Research (11 papers). Atif A Hashmi is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (23 papers) and HER2/EGFR in Cancer Research (11 papers). Atif A Hashmi collaborates with scholars based in Pakistan, United States and Afghanistan. Atif A Hashmi's co-authors include Naveen Faridi, Muhammad Muzzammil Edhi, Muhammad Irfan, Amir Khan, Zubaida Fida Hussain, Amna Khurshid, Mehmood Khan, Samreen Naz, Huda Asif and Saroona Haroon and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journals of Gerontology Series A and Cancer Discovery.

In The Last Decade

Atif A Hashmi

126 papers receiving 1.4k citations

Peers

Atif A Hashmi
Ahmet Bılıcı Türkiye
Seyed Rasoul Zakavi Iran
Maria Tolia Greece
Nurullah Zengin Türkiye
Frank S. Fan Taiwan
Letizia Gnetti Italy
Suresh C. Sharma India
Indrajit Fernando United Kingdom
Νicolas Tsavaris Greece
Μohammad Mohammadianpanah Iran
Ahmet Bılıcı Türkiye
Atif A Hashmi
Citations per year, relative to Atif A Hashmi Atif A Hashmi (= 1×) peers Ahmet Bılıcı

Countries citing papers authored by Atif A Hashmi

Since Specialization
Citations

This map shows the geographic impact of Atif A Hashmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atif A Hashmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atif A Hashmi more than expected).

Fields of papers citing papers by Atif A Hashmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atif A Hashmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atif A Hashmi. The network helps show where Atif A Hashmi may publish in the future.

Co-authorship network of co-authors of Atif A Hashmi

This figure shows the co-authorship network connecting the top 25 collaborators of Atif A Hashmi. A scholar is included among the top collaborators of Atif A Hashmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atif A Hashmi. Atif A Hashmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Sukrit, John D. Chodera, Bo Liu, et al.. (2025). Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding. Cancer Discovery. 16(2). 235–249. 3 indexed citations
2.
Hashmi, Atif A, Hannah Y. Wen, Melissa P. Murray, et al.. (2025). Clinicopathological features of microinvasive lobular carcinoma. Histopathology. 87(2). 235–245.
3.
Khan, Ibrahim, et al.. (2025). Diagnostic Accuracy of FDG PET-CT in Lymph Nodal Staging of Lung Cancer. Cureus. 17(1). e77880–e77880. 1 indexed citations
4.
Hashmi, Atif A, et al.. (2024). Risk Factors of Oral Squamous Cell Carcinoma with Special Emphasis on Areca Nut Usage and Its Association with Clinicopathological Parameters and Recurrence. International Journal of Surgical Oncology. 2024(1). 9725822–9725822. 5 indexed citations
5.
Khan, Javeria, et al.. (2024). AstraZeneca COVID-19 Vaccine and Diabetes Mellitus: A Prospective Clinical Study Regarding Vaccine Side Effects. Cureus. 16(1). e51583–e51583. 2 indexed citations
6.
Hashmi, Atif A, et al.. (2024). Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma. Disease Markers. 2024. 1–10. 3 indexed citations
7.
Anwar, Adnan, et al.. (2023). Overall Clinical Features of Type 2 Diabetes Mellitus With Respect to Gender. Cureus. 15(3). e35771–e35771. 12 indexed citations
8.
Aslam, Anum, et al.. (2023). The Common Systemic and Local Adverse Effects of the Sinovac COVID-19 Vaccine: An Observational Study From Pakistan. Cureus. 15(5). e38564–e38564. 4 indexed citations
9.
Sultana, Shazia, et al.. (2023). Severity of Adverse Effects of Sinovac COVID-19 Vaccine in Postmenopausal Women: A Multicenter Experience From Pakistan. Cureus. 15(10). e46682–e46682. 1 indexed citations
10.
Tinelli, Andrea, Ottavia D’Oria, Andrea Morciano, et al.. (2023). Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Comprehensive Multidisciplinary Update. Medicina. 59(8). 1371–1371. 8 indexed citations
11.
Gazzaz, Zohair Jamil, et al.. (2023). Association Between Pfizer COVID-19 Vaccine Adverse Effects and Diabetes Mellitus: A Prospective Multicenter Study. Cureus. 15(11). e48263–e48263. 3 indexed citations
12.
Khan, Hamza, et al.. (2023). Common Side Effects of Pfizer COVID-19 Vaccine: An Experience From Pakistan. Cureus. 15(6). e40878–e40878. 3 indexed citations
13.
14.
Hashmi, Atif A, et al.. (2023). Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC). Cureus. 15(7). e41941–e41941. 2 indexed citations
15.
16.
17.
Hashmi, Atif A, et al.. (2020). Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma. Cureus. 12(10). e10802–e10802. 1 indexed citations
18.
Hashmi, Atif A, et al.. (2018). Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients. World Journal of Surgical Oncology. 16(1). 1–1. 75 indexed citations
19.
Hashmi, Atif A, Zubaida Fida Hussain, Muhammad Irfan, et al.. (2017). Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters. World Journal of Surgical Oncology. 15(1). 89–89. 13 indexed citations
20.
Haroon, Saroona, et al.. (2013). Ki67 Index in Breast Cancer: Correlation with Other Prognostic Markers and Potential in Pakistani Patients. Asian Pacific Journal of Cancer Prevention. 14(7). 4353–4358. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmet Bılıcı Breakdown of academic impact, for papers by Seyed Rasoul Zakavi Breakdown of academic impact, for papers by Maria Tolia Breakdown of academic impact, for papers by Nurullah Zengin Breakdown of academic impact, for papers by Frank S. Fan Breakdown of academic impact, for papers by Letizia Gnetti Breakdown of academic impact, for papers by Suresh C. Sharma Breakdown of academic impact, for papers by Indrajit Fernando Breakdown of academic impact, for papers by Νicolas Tsavaris Breakdown of academic impact, for papers by Μohammad Mohammadianpanah
Rankless by CCL
2026